Analyst Ranking
Top 4%
#213 out of 5523 analysts
Average Return
+16.41%
Win Rate
44%117 out of 264
Risk vs Reward
Poor
Good

Laura Chico's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Longboard Pharmaceuticals IncLBPH
+658.28%$5.13$38.90
2023-10-12 -
2024-10-11
Buy
Edgewise Therapeutics IncEWTX
+560.25%$5.51$36.38
2023-11-10 -
2024-11-08
Buy
Dianthus Therapeutics IncDNTH
+363.04%$23.65$109.51
2025-08-21 -
2026-08-20
Buy
Dianthus Therapeutics IncDNTH
+357.27%$18.84$86.15
2025-05-13 -
2026-05-12
Buy
Ovid Therapeutics IncOVID
+314.00%$0.50$2.07
2025-03-12 -
2026-03-11
Buy

Laura Chico's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Maze Therapeutics IncMAZE
4Buy$48.00+78.77%Reiterates
7 days ago
Travere Therapeutics IncTVTX
18Buy$76.00+23.44%Reiterates
8 days ago
Xenon Pharmaceuticals IncXENE
12Buy$55.00+49.78%Maintains
12 days ago
Sionna Therapeutics IncSION
3Hold$6.00+17.19%Maintains
15 days ago
Pharvaris NvPHVS
11Buy$50.00+56.69%Maintains
21 days ago
Ultragenyx Pharmaceutical IncRARE
17Hold$23.00+59.61%Maintains
a month ago
Ardelyx IncARDX
18Buy$9.00+163.93%Reiterates
a month ago
Climb Bio IncCLYM
6Buy$20.00+70.36%Reiterates
a month ago
Vera Therapeutics IncVERA
11Hold$34.00+4.62%Reiterates
a month ago
Alto Neuroscience IncANRO
8Hold$26.00-2.48%Maintains
2 months ago
Jade Biosciences IncJBIO
10Buy$47.00+227.53%Maintains
2 months ago
Biocryst Pharmaceuticals IncBCRX
3Buy$20.00+136.13%Maintains
2 months ago
Larimar Therapeutics IncLRMR
8Buy$11.00+247.00%Maintains
2 months ago
Dianthus Therapeutics IncDNTH
16Buy$122.00+38.90%Maintains
2 months ago
Stoke Therapeutics IncSTOK
12Buy$40.00+56.86%Maintains
2 months ago
Neurocrine Biosciences IncNBIX
14Buy$194.00+38.14%Maintains
2 months ago
Biogen IncBIIB
19Hold$215.00-5.99%Maintains
2 months ago
Viridian Therapeutics IncVRDN
12Buy$43.00+109.04%Maintains
3 months ago
Praxis Precision Medicines IncPRAX
14Sell$162.00-43.29%Maintains
4 months ago
Edgewise Therapeutics IncEWTX
13Buy$52.00+30.69%Maintains
4 months ago
Solid Biosciences IncSLDB
7Buy$16.00+119.78%Reiterates
4 months ago
Pepgen IncPEPG
15Buy$4.00+54.44%Maintains
5 months ago
Denali Therapeutics IncDNLI
11Buy$23.00+9.63%Maintains
5 months ago
Ovid Therapeutics IncOVID
4Buy$7.00+184.55%Reiterates
5 months ago
Apellis Pharmaceuticals IncAPLS
14Hold$18.00-56.13%Maintains
7 months ago
Gossamer Bio IncGOSS
7Hold$80.00+594.44%Downgrades
7 months ago
Astria Therapeutics IncATXS
10Hold$13.00+3.34%Downgrades
a year ago
Tourmaline Bio IncTRML
3Hold$48.00N/ADowngrades
a year ago
Vigil Neuroscience IncVIGL
11Hold$8.00N/ADowngrades
a year ago
Sage Therapeutics IncSAGE
7Hold$6.00N/AReiterates
2 years ago
Longboard Pharmaceuticals IncLBPH
7Buy$44.00N/AMaintains
2 years ago
Voyager Therapeutics IncVYGR
3Hold$7.00N/AMaintains
2 years ago
Rallybio CorpRLYB
4Buy$88.00N/AMaintains
2 years ago
Design Therapeutics IncDSGN
5Hold$5.00N/AReiterates
3 years ago
Karuna Therapeutics IncKRTX
5Hold$330.00N/ADowngrades
3 years ago
Biomarin Pharmaceutical IncBMRN
4HoldN/AN/AInitiates Coverage On
3 years ago
Chinook Therapeutics IncKDNY
3Hold$42.00N/ADowngrades
3 years ago
Impel Pharmaceuticals IncIMPLQ
2Hold$5.00N/ADowngrades
4 years ago
Taysha Gene Therapies IncTSHA
2Buy$5.00N/AMaintains
4 years ago
Biohaven Pharmaceutical Holding Co LtdBHVN1
1Hold$148.50N/ADowngrades
4 years ago
Viela Bio IncVIE
2HoldN/AN/ADowngrades
6 years ago
Acer Therapeutics IncACER
2Buy$40.00N/AReinstates
8 years ago
Paratek Pharmaceuticals IncPRTK
2BuyN/AN/ADowngrades
9 years ago
Bioverativ IncBIVV
1HoldN/AN/ADowngrades
9 years ago
Corbus Pharmaceuticals Holdings IncCRBP
1Buy$720.00N/AInitiates Coverage On
9 years ago
Cidara Therapeutics IncCDTX
1Strong Buy$280.00N/AInitiates Coverage On
9 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.